Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy

作者：Jia Jia, Lili Mao, Jing Lin, W. Li, Pei Yuan, Lei Guo, Jie Dai, Caili Li, Xue Bai, Zhongwu Li, Yu Chen, Jun Guo, Jianming Ying, Lu Si · 发表于：Frontiers of Medicine · 年份：2024 · DOI：10.1007/s11684-023-1046-2 · 被引用次数：3 · 研究领域：Cancer and Skin Lesions、Hedgehog Signaling Pathway Studies